title: A prospective, controlled, randomized study of the effect of a slow-release silver device on the frequency of urinary tract infection in newly catheterized patients.
abstract: OBJECTIVE
  To test the effect on urinary tract infections (UTIs) in patients needing continuous indwelling catheterization, of a newly designed urine-collecting system containing an antibacterial device which slowly releases silver ions onto the inner surface of the system.
  
  
  METHODS
  The study comprised a prospective controlled randomized trial; 213 patients fulfilled the inclusion criteria. They were randomized to a urine drainage system (comprising a Unometer 400 metering system or PP 2000N closed urine-bag system, both from Maersk Medical, Denmark) either with or without the antibacterial device. The efficacy was assessed as the number of UTIs and the time to infection in the 170 patients eligible for analysis.
  
  
  RESULTS
  There were fewer UTIs in those using the system containing the antibacterial device (19% vs 24%), but the difference was not statistically significant (P < 0.05).
  
  
  CONCLUSIONS
  The potential importance of different infection routes were highlighted, suggesting that modifications to Foley catheters and urine-collecting systems attempting to prevent UTIs should focus not only on the intraluminal pathway, but on the internal and external pathways of infection.
authors.affiliation: Maersk Medical A/S, Lynge, Denmark.
authors.forename: T
authors.initials: T
authors.lastname: Reiche
authors.forename: G
authors.initials: G
authors.lastname: Lisby
authors.forename: S
authors.initials: S
authors.lastname: Jørgensen
authors.forename: A B
authors.initials: AB
authors.lastname: Christensen
authors.forename: J
authors.initials: J
authors.lastname: Nordling
mesh_terms: D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D002408:Catheters, Indwelling; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012834:Silver / Q000008:administration & dosage*; D016896:Treatment Outcome; D014546:Urinary Catheterization / Q000009:adverse effects / Q000295:instrumentation; D014552:Urinary Tract Infections / Q000517:prevention & control*
chemical_list: D000900:Anti-Bacterial Agents; D003692:Delayed-Action Preparations; D012834:Silver